5 big analyst AI moves: iPhone launch to be negative for Apple stock

Analyst coverage in AI chips and endpoints was split: Macquarie upgraded Broadcom to Outperform, citing a $40B+ fiscal 2028 spend forecast from Anthropic compute ramp and raising its EPS estimate by 12% with a $490 price target (+12%); Baird reiterated Nvidia Outperform, pointing to ~70% YoY fiscal 2028 revenue growth on ~65% hyperscaler capex growth and $1.3T AI spending by 2027. Offsetting this, KeyBanc reiterated Apple Underweight ($250) on the Sept. 9 iPhone launch as a likely negative catalyst (historically modest negative post-event reaction), while GLJ called Tesla’s Cybercab launch “sell-the-news” after only 45 DMV-registered registrations. Piper Sandler upgraded Tempus AI to Overweight, lifting its price target to $76 from $56, supported by the Personalis acquisition path and FDA progress in tumor-only diagnostics.

Analysis

Near-term, the market is rewarding exposure to the AI spend chain that has both demand visibility and pricing power: AVGO sits in the sweet spot because custom silicon is moving from pilot to budgeted infrastructure, while the software mix cushions the margin hit from faster AI semis growth. The second-order tell is that AI capex is broadening beyond a single winner-take-all GPU narrative; that is constructive for NVDA’s absolute revenue line, but it also means investors should expect a more competitive mix of suppliers and a lower-quality gross margin stack over time.

The clearer tactical weakness is in names where the stock embeds a flawless product-cycle narrative but the incremental catalyst is mostly a valuation event. AAPL looks vulnerable over the next 1-3 months if pricing is used to defend margin rather than accelerate units, because either choice narrows upside and invites multiple compression. TSLA has the opposite problem: the market is paying for a network effect, while the launch appears to have validated engineering progress more than monetization, so the burden of proof shifts to regulatory scaling and actual paid demand over the next 6-18 months.

Contrarian read: consensus may be underestimating how much AI capex can keep growing even if returns are delayed, which argues against fighting NVDA/AVGO too early. But consensus may also be overconfident that every AI infrastructure winner converts spend into durable margin expansion; if customer concentration rises or pricing competition intensifies, the multiple can stop expanding even with strong top-line growth. For TEM, the bar is now execution rather than narrative, and that makes it a cleaner event-driven long than the more crowded mega-cap AI names.

Key Decisions for Investors

• Buy AVGO on weakness or via a 3-6 month call spread; thesis is that the stock rerates as the market prices a multi-year custom-silicon annuity, with downside limited unless AI gross margins deteriorate faster than expected.
• Maintain/add NVDA on pullbacks as the highest-quality liquidity beneficiary of hyperscaler capex; risk/reward stays favorable for 6-12 months unless forward supply commentary or capex guides down.
• Short TSLA into post-launch strength or use put spreads for the next 1-2 months; catalyst risk remains positive only if the company can show paid deployment, broader geofenced coverage, or a concrete commercialization timetable.
• Reduce AAPL exposure ahead of the iPhone event or hedge with short-dated puts; the falsifier is a pricing plan that clearly expands gross margin without evidence of demand elasticity.
• Initiate a smaller TEM long on the upgrade, but size for execution risk; hold for 3-6 months and cut if regulatory or integration milestones slip, since the re-rating depends on converting pipeline visibility into payer economics.